GlaxoSmithKline Pharmaceuticals surges on reporting 38% jump in Q1 net profit

07 May 2013 Evaluate

Glaxosmithkline Pharmaceuticals is currently trading at Rs. 2400.00, up by 82.60 points or 3.56% from its previous closing of Rs. 2317.40 on the BSE.

The scrip opened at Rs. 2320.00 and has touched a high and low of Rs. 2522.00 and Rs. 2310.25 respectively. So far 21877 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2522.00 on 07-March-2013 and a 52 week low of Rs. 1916.00 on 04-Jul-2012.

Last one week high and low of the scrip stood at Rs. 2522.00 and Rs. 2235.00 respectively. The current market cap of the company is Rs. 20591.30 crore.

The promoters holding in the company stood at 50.67% while Institutions and Non-Institutions held 34.17% and 15.16% respectively.

GlaxoSmithKline Pharmaceuticals has reported results for the first quarter ended March 31, 2013

On standalone basis, the company has posted a rise of 37.53% in its net profit at Rs 169.01 crore for the quarter ended March 31, 2013 as compared to Rs 122.89 crore for the same quarter in the previous year. Total income of the company has increased marginally by 1.51% at Rs 713.84 crore for quarter under review as compared to Rs 703.19 crore for the quarter ended March 31, 2012.

GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.

Glaxosmithkline Phar Share Price

2598.00 -25.95 (-0.99%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×